AAMC, Thalamus Announce New Collaboration to Improve Transition to Residency April 27, 2023April 27, 2023 by Team Thalamus
Thalamus’ Response to the NRMP Call for Public Comment Regarding Consideration of a Two-Phased Main Residency Match October 3, 2022October 3, 2022 by Jason Reminick
Thalamus’ response and support of the GME Community affected by Hurricane Fiona September 28, 2022September 26, 2022 by Jason Reminick
The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 5: How Thalamus will support Preference Signaling for Programs in 2022-2023 June 9, 2022June 9, 2022 by Team Thalamus
The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 4: Recommendations for Applicants and Programs on how to use Preference Signaling June 9, 2022June 9, 2022 by Team Thalamus
The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 3: How Preference Signaling Affected 2021-2022 Application, Interview and Match Statistics June 9, 2022June 9, 2022 by Team Thalamus
The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 2: The Introduction of Preference Signaling to GME June 9, 2022June 9, 2022 by Team Thalamus
The Ultimate Guide to Preference Signaling for Medical Residency Applicants and Programs 2022-2023. Part 1: The Origins of Preference Signaling June 9, 2022June 9, 2022 by Team Thalamus
How Thalamus’ Technology innovates and optimizes Diversity, Equity, and Inclusion in GME Recruitment. April 28, 2022April 28, 2022 by Team Thalamus
